CMN Webinars - Your Gateway to CRISPR Medicine
The CMN Webinars are hosted and organised by CRISPR Medicine News and will give you the latest updates from the CRISPR Medicine field. In collaboration with our growing global CRISPR Medicine community, we will select relevant topics and invite the speakers from the field.
If you have any questions or requests for webinars, please contact us at: sales@crisprmedicinenews.com.
Interested in hosting a webinar on CMN?
Contact us to learn more about our CMN Webinars package.
+35k readers | +27k followers | Top-1 CRISPR News Site | sales@crisprmedicinenews.com
Past Webinars - Available on-demand
April 16 - Advances and limitations of in vivo viral delivery systems for therapeutic gene editing
March 19 - (Epi)genome editing in CAR T cells
Feb 12 - Meeting FDA Guidelines for CRISPR sgRNA Purity with Orthogonal Chromatography
Nov 27 - Targeting Drug Resistance in Solid Tumours Using CRISPR-Directed Gene Editing
Nov 6 - CRISPR & Gene Drives: New Tools Being Developed in the Effort Against Malaria
Oct 30 - Release the brake: CRISPR editing to boost CAR natural killer cell efficacy
CRISPR Clinical Trials: Current Progress and Future Perspectives in In Vivo Approaches
CRISPR Clinical Trials: Current Progress and Future Perspectives in Ex Vivo Approaches
Strategies and Tools for Ex Vivo and In Vivo Genome Editing
CRISPR-based genetic screens enable the discovery of oncology drug targets, predictive biomarkers, and mechanisms of resistance
CRISPR Helps Decode the Epigenetic Mysteries of Cancer
A Dual CRISPR Strategy Eliminates HIV in Humanised Mice
CATCHing Tumour DNA: Using CRISPR to Detect Cancer in the Gut
Disrupting the Care of Cardiovascular Disease With Single-Course Gene Editing Medicines
Taking the Guesswork Out of Drug Development: CRISPR-Select Validates Drug Targets and Drug Responders Early and Conclusively
Clinical-Grade gRNA for Genomic Medicines: Making Sense of the CRISPR Regulatory Landscape
Developing Therapies for Congenital Muscular Dystrophies
CRISPR/Cas9-Mediated Gene Editing of Haematopoietic Stem and Progenitor Cells for Friedreich’s Ataxia
Enhancing T Cell Function for Cancer Immunotherapy With CRISPR
Dec. 6th 2022 - Engineering Approaches to Improve CRISPR Technologies
Nov. 30 2022 - Development of CRISPR/Cas9-based Therapies against Alzheimer's Disease
October 26th 2022 - A Novel Non-viral Cargo Delivery Platform: The First in a New Class
September 28th 2022 - Epigenomic Editing Ameliorates Detrimental Effects of Adolescent Alcohol Exposure
September 21st 2022 - Gene Editing for Junctional Epidermolysis Bullosa
June 29th 2022 - Multiplexed Genome Regulation In Vivo with Hyper-efficient Cas12a
June 15th 2022 - The TCR Therapy Revival: Engineering T cells with WT1-specific receptors to fight hematological and solid malignancies
May 25th 2022: Deliver CRISPR to the Brain - A New Treatment Strategy for Mucopolysaccharidoses
April 27th 2022 - Controllable Genome Editing with Split-engineered Base Editors
March 30th 2022 - CRISPR-based Control of Insect-borne Diseases
January 26th 2022 - CRISPR and Metachromatic Leukodystrophy (MLD)
December 8th 2021 - CRISPR Off-Targets-II
November 17th 2021 - Rare Diseases and CRISPR
November 5th 2021 - CRISPR On/Off (Prediction, Modelling)
June 23th 2021 - CRISPR Off-Targets
May 26th 2021 - CRISPR Delivery Systems
April 20th 2021 - Certainty After CRISPR
